Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC

Affiliations

¹ Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.
² Department of Medical Oncology, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, China.
³ Department of Medical Oncology, Jinling Hospital, Nanjing, China.

Published Erratum

Mubalake Abudoureyimu et al. Front Oncol. 2020.

. 2020 May 5:10:701.

doi: 10.3389/fonc.2020.00701. eCollection 2020.

¹ Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.
² Department of Medical Oncology, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, China.
³ Department of Medical Oncology, Jinling Hospital, Nanjing, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2019.01182.].

Keywords: HCC; adenovirus; gene-targeted oncolytic viral therapy; immunotherapy; virus engineering.

Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.
Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X. Abudoureyimu M, et al. Front Oncol. 2019 Nov 8;9:1182. doi: 10.3389/fonc.2019.01182. eCollection 2019. Front Oncol. 2019. PMID: 31781493 Free PMC article. Review.